TheraRadar
← Back
Data updated: Jun 28, 2026

KENVUE BRANDS

Specialty
Pharmaceuticals

KENVUE BRANDS is a specialty pharmaceutical company with 28 FDA-approved products.

1984
Since
28
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
20 Small Molecules

KENVUE BRANDS's Key Drugs

KENVUE BRANDS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

KENVUE BRANDS's Recent FDA Approvals

New NDA/BLA approvals for KENVUE BRANDS over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

KENVUE BRANDS's Therapeutic Areas

Disease areas where KENVUE BRANDS has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

KENVUE BRANDS Pipeline Snapshot

Active clinical trials for KENVUE BRANDS across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling